CTOs on the Move

Ratio Therapeutics

www.ratiotx.com

 
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer. Ratio Therapeutics` Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Jacob Hesterman
Chief Data Officer Profile

Similar Companies

TotalAncillary

Comprehensive Solution for Revenue Generating Medical Ancillary Services

Phlow

Securing our nation’s pharmaceuticals through U.S. Manufacturing.

Ionetix

Ionetix Corporation is a pioneering radiopharmaceutical end to end solutions provider for cardiac PET. Cardiac PET with Ammonia N-13.

MANCEF

MANCEF is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Unique Pharmaceuticals

Unique Pharmaceuticals is a Temple, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.